Clinical trials show tirzepatide produces 20%+ greater weight loss than semaglutide in head-to-head comparisons, making it an effective next step for patients experiencing a plateau
Who GLP-1 is for Adults seeking medically supervised weight loss, typically with a higher BMI or a weight-related health concern, who clear the eligibility screen and have no contraindications (notably no personal or family history of medullary thyroid carcinoma or MEN 2, and not pregnant or breastfeeding)
The response was uniformly dismissive
1 Smith, E., Ramirez, B., & Johnson, K
We dispense only FDA-approved medications, review labs when indicated, and integrate supportive wellness services such as IV therapy and hormone optimization
Blood pressure improvements are common, with systolic pressure dropping by 5 to 10 mmHg on average